CIBC Private Wealth Group LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 64.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 596 shares of the biotechnology company’s stock after acquiring an additional 233 shares during […] - 2025-04-10 08:53:11
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average 12-month target price […] - 2025-04-02 05:35:01
Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 362.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,903 shares of the biotechnology company’s stock after purchasing an additional 131,600 shares during the quarter. Korea […] - 2025-03-31 08:45:10
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) was the target of some unusual options trading on Thursday. Traders bought 5,111 call options on the company. This represents an increase of 273% compared to the typical volume of 1,372 call options. Analyst Ratings Changes BMRN has been the subject of several recent analyst reports. Wedbush […] - 2025-03-28 07:07:10
Natixis Advisors LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,738 shares of the biotechnology company’s stock, valued at approximately $1,297,000. A number of other institutional investors and hedge […] - 2025-03-26 07:50:56
EverSource Wealth Advisors LLC lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 91.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 634 shares of the biotechnology company’s stock after selling 6,469 shares during the quarter. EverSource Wealth Advisors […] - 2025-03-21 08:25:03
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday. BMRN has been the subject of several other research reports. Oppenheimer upgraded shares of BioMarin Pharmaceutical from a “market perform” rating to an “outperform” rating […] - 2025-03-18 06:12:54
M&T Bank Corp lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,085 shares of the biotechnology company’s stock after purchasing an additional 616 shares during the period. M&T Bank Corp’s holdings in BioMarin Pharmaceutical were worth $466,000 at the […] - 2025-03-14 08:08:58
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 12-month price […] - 2025-03-05 07:12:53
Y Intercept Hong Kong Ltd lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 83.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,711 shares of the biotechnology company’s stock after selling 23,519 shares during the quarter. […] - 2025-03-04 09:05:03
Sanctuary Advisors LLC lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 76.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,045 shares of the biotechnology company’s stock after selling 16,288 shares during the quarter. Sanctuary […] - 2025-03-04 08:22:48
New York State Common Retirement Fund reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,645 shares of the biotechnology company’s stock after selling 4,600 shares during […] - 2025-02-28 09:04:56
Principal Securities Inc. boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 24.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,749 shares of the biotechnology company’s stock after buying an additional 339 shares […] - 2025-02-26 10:10:52
Asset Management One Co. Ltd. raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 76,785 shares of the biotechnology company’s stock after acquiring an additional 283 shares during the period. Asset Management One Co. Ltd.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-02-19 10:44:54
Rhumbline Advisers boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 2.0% in the fourth quarter, Holdings Channel reports. The firm owned 556,255 shares of the biotechnology company’s stock after purchasing an additional 11,025 shares during the quarter. Rhumbline Advisers’ holdings in BioMarin Pharmaceutical were worth $36,563,000 as of its most recent […] - 2025-02-19 09:03:32
Entropy Technologies LP acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,604 shares of the biotechnology company’s stock, valued at approximately $500,000. Other large […] - 2025-02-13 10:12:51
State of Alaska Department of Revenue cut its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 25.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 21,730 shares of the biotechnology company’s stock after selling 7,495 shares during the quarter. State […] - 2025-02-13 09:38:52
Janney Montgomery Scott LLC trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 34.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,671 shares of the biotechnology company’s stock after selling 4,029 shares during the quarter. Janney Montgomery Scott LLC’s […] - 2025-02-10 18:10:54
Robeco Institutional Asset Management B.V. cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 58.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 86,574 shares of the biotechnology company’s stock after selling 124,092 shares during the […] - 2025-02-03 08:57:17
BMRN institutional holdings
The following institutional investment holdings of BMRN have been identified
Date
ETF ISIN/Name
Num Shares
Book value
Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119
Stack trace:
#0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query()
#1 {main}
thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119